DELEQUAMINE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C18H26N2O3S
Molecular Weight	350.476
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@]12CCCN([C@@]1([H])C[C@]3([H])N(CCC4=C3C=CC(OC)=C4)C2)S(C)(=O)=O

InChI

InChIKey=JKDBLHWERQWYKF-JLSDUUJJSA-N

InChI=1S/C18H26N2O3S/c1-23-15-5-6-16-13(10-15)7-9-19-12-14-4-3-8-20(24(2,21)22)17(14)11-18(16)19/h5-6,10,14,17-18H,3-4,7-9,11-12H2,1-2H3/t14-,17+,18+/m1/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2570150 | https://www.ncbi.nlm.nih.gov/pubmed/7871091

Delequamine is a selective antagonist of alpha2 adrenoreceptor, developed by Syntex Research. The compound was investigated for the treatment of erectile dysfunction and was modestly effective in younger (less than 45 years) subjects.

Approval Year

PubMed

Title	Date	PubMed
The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.	2003 May	12644843

Patents

Name

Type

Language

DELEQUAMINE

Official Name

English

delequamine [INN]

Common Name

English

(8AR,12AS,13AS)-5,8,8A,9,10,11,12,12A,13,13A-DECAHYDRO-3-METHOXY-12-(METHYLSULFONYL)-6H-ISOQUINO(2,1-G)(1,6)NAPHTHYRIDINE

Common Name

English

Delequamine [WHO-DD]

Common Name

English

Code System Code Type Description

PUBCHEM

60713